EMA Authorised: Onureg (azacitidine) — Bristol-Myers Squibb Pharma EEIG

View source ↗

Summary

The European Medicines Agency authorised Onureg (azacitidine) for acute myeloid leukemia in adults in the European Union, with Bristol-Myers Squibb Pharma EEIG …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

Status: Authorised. Therapeutic area: Leukemia, Myeloid, Acute. MAH: Bristol-Myers Squibb Pharma EEIG. Decision date: 08/01/2026